Perfect storm for lower demand: less socializing, pot and gummies replacing it, GLP-1s reducing appetite for everything, Covid leaving some people unable to process it
— Amy Nixon (@texasrunnerDFW) February 19, 2026
GLP-1 weight-loss drugs are being linked to significant reductions in alcohol consumption
It’s not just food — weight-loss drugs have seen some users cutting back on alcohol and other beverages.
Haas said many of his patients who take GLP-1s report “reduced cravings and lower alcohol consumption as a result.” That means they’re likely spending less on alcohol when they go out, too.
Financial analysts have observed a similar trend. About 44 percent of GLP-1 users drink less after starting the medication, and 82 percent maintain those habits even after stopping, according to a March 2025 survey by EY-Parthenon.
Alcohol stocks tumbled last summer, and rising GLP-1 use may have contributed to this dip in sales, according to Forbes. Brown-Forman, the company that produces Jack Daniel’s whiskey, has warned the industry is facing pressure because of a number of factors, including weight-loss drugs and lower demand from younger adults, the outlet reports.
https://www.the-independent.com/news/world/americas/weight-loss-drugs-economic-impact-b2912527.html